FindTrial
Sign In

Lorazepam 1 mg

DRUG5 trials

Sponsors

University of Sao Paulo, University of Arizona, University Hospital, Bonn, University of Wisconsin, Madison, University Hospital, Basel, Switzerland

Conditions

Delirium Confusional StateIUDInfertilityObsessive-compulsive Disorder (OCD)Oxytocin, Lorazepam, Anti-Anxiety Agents, Physiological Effects of DrugsPainSubfertility

Phase 1

Psilocybin for Treatment of Obsessive Compulsive Disorder
CompletedNCT03300947
University of ArizonaObsessive-compulsive Disorder (OCD)
Start: 2019-01-02End: 2023-12-30Updated: 2024-08-30
Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity
CompletedNCT03829839
University Hospital, BonnOxytocin, Lorazepam, Anti-Anxiety Agents, Physiological Effects of Drugs
Start: 2016-03-03End: 2017-08-16Updated: 2019-04-17

Phase 2

Prescribing Lorazepam for IUD Insertion: Pilot Feasibility Study
WithdrawnNCT06496854
University of Wisconsin, MadisonIUD, Pain
Start: 2025-10-31End: 2026-01-31Updated: 2025-10-30

Phase 4

Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-Index
Not yet recruitingNCT07428681
University Hospital, Basel, SwitzerlandDelirium Confusional State
Start: 2027-03-01End: 2029-02-01Target: 260Updated: 2026-02-27

Unknown Phase

Analgesia for Endometrial Scratching
CompletedNCT02863614
University of Sao PauloInfertility, Subfertility
Start: 2015-05-31End: 2017-05-31Updated: 2018-05-08

Related Papers

A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive–compulsive disorder
Journal of Psychopharmacology2026-03-13
Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report
Heliyon2022-12-0126 citations